{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["C3b", "Complement system", "Disseminated intravascular coagulation", "Lipopolysaccharide", "Salvianolic acid A"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36127691", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "20"}], "Language": ["eng"], "ELocationID": ["245", "10.1186/s12906-022-03720-z"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "20"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.", "Pagination": {"StartPage": "245", "MedlinePgn": "245"}, "Abstract": {"AbstractText": ["Disseminated intravascular coagulation (DIC) is a syndrome characterized by coagulopathy, microthrombus, and multiple organ failure. The complement system in DIC is overactivated, and the functions of complement and coagulation pathways are closely related. Our previous screening revealed that salvianolic acid A (SAA) has anti-complement activity. The hyper-activated complement system was involved in the lipopolysaccharide (LPS) induced DIC in rats. The effects of SAA anti-complement action on LPS-induced DIC in rats were investigated.", "The complement activity of the classical pathway and alternative pathway was detected through an in vitro hemolysis assay. The binding sites of SAA and complement C3b were predicted by molecular docking. LPS-induced disseminated coagulation experiments were performed on male Wistar rats to assess coagulation function, complement activity, inflammation, biochemistry, blood routine, fibrinolysis, and survival.", "SAA had an anti-complement activity in vivo and in vitro and inhibited the complement activation in the classical and alternative pathway of complement. The infusion of LPS into the rats impaired the coagulation function, increased the plasma inflammatory cytokine level, complemented activation, reduced the clotting factor levels, fibrinogen, and platelets, damaged renal, liver, and lung functions, and led to a high mortality rate (85%). SAA treatment of rats inhibited complement activation and attenuated the significant increase in D-dimer, interleukin-6, alanine aminotransferase, and creatinine. It ameliorated the decrease in plasma levels of fibrinogen and platelets and reversed the decline in activity of protein C and antithrombin III. The treatment reduced kidney, liver, and lung damage, and significantly improved the survival rate of rats (46.2 and 78.6% for the low- and high-dose groups, respectively).", "SAA reduced LPS-induced DIC by inhibiting complement activation. It has considerable potential in DIC treatment."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Zhang", "ForeName": "Qi-Yun", "Initials": "QY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Guo", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Xu", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Wei", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Zhou", "ForeName": "Shu-Ting", "Initials": "ST"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Lu", "ForeName": "Qing-Yu", "Initials": "QY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China."}], "LastName": "Guo", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. sunqy@hotmail.com."}, {"Identifier": [], "Affiliation": "Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, 550014, China. sunqy@hotmail.com."}], "LastName": "Sun", "ForeName": "Qian-Yun", "Initials": "QY"}], "GrantList": [{"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHRC2016-4018", "Agency": "Guizhou Provincial Science and Technology Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Coagulation Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Caffeic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactates"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein C"}, {"RegistryNumber": "51622542XO", "NameOfSubstance": "salvianolic acid A"}, {"RegistryNumber": "80295-43-8", "NameOfSubstance": "Complement C3b"}, {"RegistryNumber": "9000-94-6", "NameOfSubstance": "Antithrombin III"}, {"RegistryNumber": "9001-32-5", "NameOfSubstance": "Fibrinogen"}, {"RegistryNumber": "AYI8EX34EU", "NameOfSubstance": "Creatinine"}, {"RegistryNumber": "EC 2.6.1.2", "NameOfSubstance": "Alanine Transaminase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Alanine Transaminase"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antithrombin III"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Coagulation Factors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Caffeic Acids"}, {"QualifierName": [], "DescriptorName": "Complement Activation"}, {"QualifierName": [], "DescriptorName": "Complement C3b"}, {"QualifierName": [], "DescriptorName": "Creatinine"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Disseminated Intravascular Coagulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Fibrinogen"}, {"QualifierName": [], "DescriptorName": "Interleukin-6"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lactates"}, {"QualifierName": [], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein C"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}], "CoiStatement": "The authors declare that they have no conflicts of interest regarding this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Thachil J. Disseminated intravascular coagulation - new pathophysiological concepts and impact on management. Expert Rev Hematol. 2016;9(8):803\u2013814. doi: 10.1080/17474086.2016.1203250.", "ArticleIdList": ["10.1080/17474086.2016.1203250", "27314681"]}, {"Citation": "Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev Hematol. 2018;11(8):663\u2013672. doi: 10.1080/17474086.2018.1500173.", "ArticleIdList": ["10.1080/17474086.2018.1500173", "29999440"]}, {"Citation": "Iba T, Levi M, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost. 2020;46(1):89\u201395. doi: 10.1055/s-0039-1694995.", "ArticleIdList": ["10.1055/s-0039-1694995", "31443111"]}, {"Citation": "Hayakawa M. Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype. J Intensive Care. 2017;5:14. doi: 10.1186/s40560-016-0200-1.", "ArticleIdList": ["10.1186/s40560-016-0200-1", "PMC5282695", "28289544"]}, {"Citation": "Levi M. Management of cancer-associated disseminated intravascular coagulation. Thromb Res. 2016;140(Suppl 1):S66\u201370. doi: 10.1016/S0049-3848(16)30101-3.", "ArticleIdList": ["10.1016/S0049-3848(16)30101-3", "27067981"]}, {"Citation": "Iba T, Watanabe E, Umemura Y, Wada T, Hayashida K, Kushimoto S, Wada H. Sepsis-associated disseminated intravascular coagulation and its differential diagnoses. J Intensive Care. 2019;7:32. doi: 10.1186/s40560-019-0387-z.", "ArticleIdList": ["10.1186/s40560-019-0387-z", "PMC6528221", "31139417"]}, {"Citation": "Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17(11):1989\u20131994. doi: 10.1111/jth.14578.", "ArticleIdList": ["10.1111/jth.14578", "31410983"]}, {"Citation": "Iba T, Connors JM, Nagaoka I, Levy JH. Recent advances in the research and management of sepsis-associated DIC. Int J Hematol. 2021;113(1):24\u201333. doi: 10.1007/s12185-020-03053-y.", "ArticleIdList": ["10.1007/s12185-020-03053-y", "PMC7775827", "33386597"]}, {"Citation": "Mollnes TE, Huber-Lang M. Complement in sepsis-when science meets clinics. FEBS Lett. 2020;594(16):2621\u20132632. doi: 10.1002/1873-3468.13881.", "ArticleIdList": ["10.1002/1873-3468.13881", "32621378"]}, {"Citation": "Zetoune FS, Ward PA. Role of complement and histones in sepsis. Front Med. 2020;7:616957. doi: 10.3389/fmed.2020.616957.", "ArticleIdList": ["10.3389/fmed.2020.616957", "PMC7785970", "33425963"]}, {"Citation": "Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol. 2004;4(2):133\u2013142. doi: 10.1038/nri1269.", "ArticleIdList": ["10.1038/nri1269", "15040586"]}, {"Citation": "Zhao X, Chen YX, Li CS. Predictive value of the complement system for sepsis-induced disseminated intravascular coagulation in septic patients in emergency department. J Crit Care. 2015;30(2):290\u2013295. doi: 10.1016/j.jcrc.2014.11.007.", "ArticleIdList": ["10.1016/j.jcrc.2014.11.007", "25547047"]}, {"Citation": "Abe T, Kubo K, Izumoto S, Shimazu S, Goan A, Tanaka T, Koroki T, Saito K, Kawana R, Ochiai H. Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation. Shock (Augusta, Ga) 2020;54(2):198\u2013204. doi: 10.1097/SHK.0000000000001504.", "ArticleIdList": ["10.1097/SHK.0000000000001504", "31917735"]}, {"Citation": "Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AW, Sperr WR, et al. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood. 2002;100(2):517\u2013523. doi: 10.1182/blood.V100.2.517.", "ArticleIdList": ["10.1182/blood.V100.2.517", "12091343"]}, {"Citation": "Sims PJ, Wiedmer T. The response of human platelets to activated components of the complement system. Immunol Today. 1991;12(9):338\u2013342. doi: 10.1016/0167-5699(91)90012-I.", "ArticleIdList": ["10.1016/0167-5699(91)90012-I", "1755945"]}, {"Citation": "Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J immunol. 2011;187(1):172\u2013180. doi: 10.4049/jimmunol.1100491.", "ArticleIdList": ["10.4049/jimmunol.1100491", "21642543"]}, {"Citation": "Oncul S, Afshar-Kharghan V. The interaction between the complement system and hemostatic factors. Curr Opin Hematol. 2020;27(5):341\u2013352. doi: 10.1097/MOH.0000000000000605.", "ArticleIdList": ["10.1097/MOH.0000000000000605", "PMC7773221", "32701617"]}, {"Citation": "Krarup A, Wallis R, Presanis JS, G\u00e1l P, Sim RB. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS ONE. 2007;2(7):e623. doi: 10.1371/journal.pone.0000623.", "ArticleIdList": ["10.1371/journal.pone.0000623", "PMC1910608", "17637839"]}, {"Citation": "Wiedmer T, Esmon CT, Sims PJ. Complement proteins C5b\u20139 stimulate procoagulant activity through platelet prothrombinase. Blood. 1986;68(4):875\u2013880. doi: 10.1182/blood.V68.4.875.875.", "ArticleIdList": ["10.1182/blood.V68.4.875.875", "3092889"]}, {"Citation": "Polley MJ, Nachman RL. Human platelet activation by C3a and C3a des-arg. J Exp Med. 1983;158(2):603\u2013615. doi: 10.1084/jem.158.2.603.", "ArticleIdList": ["10.1084/jem.158.2.603", "PMC2187348", "6604123"]}, {"Citation": "Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007;28(4):184\u2013192. doi: 10.1016/j.it.2007.02.006.", "ArticleIdList": ["10.1016/j.it.2007.02.006", "17336159"]}, {"Citation": "Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med. 1997;185(9):1619\u20131627. doi: 10.1084/jem.185.9.1619.", "ArticleIdList": ["10.1084/jem.185.9.1619", "PMC2196305", "9151899"]}, {"Citation": "Langer F, Spath B, Fischer C, Stolz M, Ayuk FA, Kr\u00f6ger N, et al. Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood. 2013;121(12):2324\u20132335. doi: 10.1182/blood-2012-10-460493.", "ArticleIdList": ["10.1182/blood-2012-10-460493", "PMC3606067", "23315166"]}, {"Citation": "Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b\u20139 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 1988;263(34):18205\u201318212. doi: 10.1016/S0021-9258(19)81346-7.", "ArticleIdList": ["10.1016/S0021-9258(19)81346-7", "2848029"]}, {"Citation": "Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y. C5a induces tissue factor activity on endothelial cells. Thromb Haemost. 1997;77(2):394\u2013398. doi: 10.1055/s-0038-1655974.", "ArticleIdList": ["10.1055/s-0038-1655974", "9157602"]}, {"Citation": "Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, et al. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J immunol. 2006;177(7):4794\u20134802. doi: 10.4049/jimmunol.177.7.4794.", "ArticleIdList": ["10.4049/jimmunol.177.7.4794", "16982920"]}, {"Citation": "Silasi-Mansat R, Zhu H, Popescu NI, Peer G, Sfyroera G, Magotti P, et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood. 2010;116(6):1002\u20131010. doi: 10.1182/blood-2010-02-269746.", "ArticleIdList": ["10.1182/blood-2010-02-269746", "PMC2924221", "20466856"]}, {"Citation": "Keshari RS, Silasi R, Popescu NI, Patel MM, Chaaban H, Lupu C, Coggeshall KM, Mollnes TE, DeMarco SJ, Lupu F. Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis. Proc Natl Acad Sci USA. 2017;114(31):E6390\u2013e6399. doi: 10.1073/pnas.1706818114.", "ArticleIdList": ["10.1073/pnas.1706818114", "PMC5547645", "28720697"]}, {"Citation": "Li ZM, Xu SW, Liu PQ. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39(5):802\u2013824. doi: 10.1038/aps.2017.193.", "ArticleIdList": ["10.1038/aps.2017.193", "PMC5943903", "29698387"]}, {"Citation": "Wu Y, Xu S, Tian XY. The effect of Salvianolic acid on vascular protection and possible mechanisms. Oxid Med Cell Longev. 2020;2020:5472096.", "ArticleIdList": ["PMC7533016", "33062143"]}, {"Citation": "Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K. Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res. 2010;126(1):e17\u201322. doi: 10.1016/j.thromres.2010.04.006.", "ArticleIdList": ["10.1016/j.thromres.2010.04.006", "20451955"]}, {"Citation": "Zhang H, Liu YY, Jiang Q, Li KR, Zhao YX, Cao C, et al. Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling. Free Radical Biol Med. 2014;69:219\u2013228. doi: 10.1016/j.freeradbiomed.2014.01.025.", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.01.025", "24486344"]}, {"Citation": "Huang J, Qin Y, Liu B, Li GY, Ouyang L, Wang JH. In silico analysis and experimental validation of molecular mechanisms of salvianolic acid A-inhibited LPS-stimulated inflammation, in RAW264.7 macrophages. Cell proliferation. 2013;46(5):595\u2013605.", "ArticleIdList": ["PMC6496881", "24033467"]}, {"Citation": "Sun QY, Bao J. Purification, cloning and characterization of a metalloproteinase from Naja atra venom. Toxicon. 2010;56(8):1459\u20131469. doi: 10.1016/j.toxicon.2010.08.013.", "ArticleIdList": ["10.1016/j.toxicon.2010.08.013", "20837040"]}, {"Citation": "Shi L, Cui H, Yang FM, Q.Y S. Purification and characterization of a new anticomplementary protein in Naja atra Venom. Chin J Biochem Mole Biol. 2019;8(9):8\u201312."}, {"Citation": "Sch\u00f6ning-Stierand K, Diedrich K, F\u00e4hrrolfes R, Flachsenberg F, Meyder A, Nittinger E, et al. ProteinsPlus: interactive analysis of protein-ligand binding interfaces. Nucleic Acids Res. 2020;48(W1):W48\u2013W53. doi: 10.1093/nar/gkaa235.", "ArticleIdList": ["10.1093/nar/gkaa235", "PMC7319454", "32297936"]}, {"Citation": "F\u00e4hrrolfes R, Bietz S, Flachsenberg F, Meyder A, Nittinger E, Otto T, et al. ProteinsPlus: a web portal for structure analysis of macromolecules. Nucleic Acids Res. 2017;45(W1):W337\u2013W343. doi: 10.1093/nar/gkx333.", "ArticleIdList": ["10.1093/nar/gkx333", "PMC5570178", "28472372"]}, {"Citation": "Morris GM, Huey R, Olson AJ. Using AutoDock for ligand-receptor docking. Current protocols in bioinformatics 2008, Chapter 8:Unit 8.14.", "ArticleIdList": ["19085980"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11(5):905\u2013919. doi: 10.1038/nprot.2016.051.", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010;24(5):417\u2013422. doi: 10.1007/s10822-010-9352-6.", "ArticleIdList": ["10.1007/s10822-010-9352-6", "PMC2881210", "20401516"]}, {"Citation": "Chen X, Tan J, Yang M, Liao ZK, Lu C, Huang Y, et al. Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide. J Nat Med. 2018;72(4):846\u2013856. doi: 10.1007/s11418-018-1215-9.", "ArticleIdList": ["10.1007/s11418-018-1215-9", "29761425"]}, {"Citation": "Othman M, Kaur H. Thromboelastography (TEG) Methods Mol Biol. 2017;1646:533\u2013543. doi: 10.1007/978-1-4939-7196-1_39.", "ArticleIdList": ["10.1007/978-1-4939-7196-1_39", "28804853"]}, {"Citation": "Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44(5):725\u201338. doi: 10.1165/rcmb.2009-0210ST.", "ArticleIdList": ["10.1165/rcmb.2009-0210ST", "PMC7328339", "21531958"]}, {"Citation": "Kulkarni HS, Lee JS, Bastarache JA, Kuebler WM, Downey GP, Albaiceta GM, Altemeier WA, Artigas A, Bates JHT, Calfee CS, et al. Update on the features and measurements of experimental acute lung injury in animals: an official american thoracic society workshop report. Am J Respir Cell Mol Biol. 2022;66(2):e1\u2013e14. doi: 10.1165/rcmb.2021-0531ST.", "ArticleIdList": ["10.1165/rcmb.2021-0531ST", "PMC8845128", "35103557"]}, {"Citation": "Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet (London, England) 2018;392(10141):75\u201387. doi: 10.1016/S0140-6736(18)30696-2.", "ArticleIdList": ["10.1016/S0140-6736(18)30696-2", "29937192"]}, {"Citation": "Zhao H, Chen H, Xiaoyin M, Yang G, Hu Y, Xie K, et al. Autophagy activation improves lung injury and inflammation in sepsis. Inflammation. 2019;42(2):426\u201339. doi: 10.1007/s10753-018-00952-5.", "ArticleIdList": ["10.1007/s10753-018-00952-5", "30645707"]}, {"Citation": "Wann SR, Chi PL, Huang WC, Cheng CC, Chang YT. Combination therapy of iPSC-derived conditioned medium with ceftriaxone alleviates bacteria-induced lung injury by targeting the NLRP3 inflammasome. J Cell Physiol. 2022;237(2):1299\u2013314. doi: 10.1002/jcp.30596.", "ArticleIdList": ["10.1002/jcp.30596", "34612516"]}, {"Citation": "Berthelsen LO, Kristensen AT, Tranholm M. Animal models of DIC and their relevance to human DIC: a systematic review. Thromb Res. 2011;128(2):103\u2013116. doi: 10.1016/j.thromres.2010.12.002.", "ArticleIdList": ["10.1016/j.thromres.2010.12.002", "21215993"]}, {"Citation": "Asakura H, Suga Y, Yoshida T, Ontachi Y, Mizutani T, Kato M, et al. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis. 2003;14(3):221\u2013228.", "ArticleIdList": ["12695743"]}, {"Citation": "Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, et al. Molecular intercommunication between the complement and coagulation systems. J Immunol. 2010;185(9):5628\u201336. doi: 10.4049/jimmunol.0903678.", "ArticleIdList": ["10.4049/jimmunol.0903678", "PMC3123139", "20870944"]}, {"Citation": "Dzik S. Complement and coagulation: cross talk through time. Transfus Med Rev. 2019;33(4):199\u2013206. doi: 10.1016/j.tmrv.2019.08.004.", "ArticleIdList": ["10.1016/j.tmrv.2019.08.004", "31672340"]}, {"Citation": "Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008;632:71\u201379.", "ArticleIdList": ["PMC2713875", "19025115"]}, {"Citation": "High KA. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. Arch Pathol Lab Med. 1988;112(1):28\u201336.", "ArticleIdList": ["2962557"]}, {"Citation": "Koyama K, Madoiwa S, Nunomiya S, Koinuma T, Wada M, Sakata A, Ohmori T, Mimuro J, Sakata Y. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Critical care . 2014;18(1):R13. doi: 10.1186/cc13190.", "ArticleIdList": ["10.1186/cc13190", "PMC4056264", "24410881"]}, {"Citation": "Takahashi H, Hanano M, Takizawa S, Tatewaki W, Fuse I, Satoh K. Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC) Rinsho ketsueki. 1988;29(3):336\u201343.", "ArticleIdList": ["3260969"]}, {"Citation": "van der Poll T, de Jonge E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):639\u2013651. doi: 10.1055/s-2001-18868.", "ArticleIdList": ["10.1055/s-2001-18868", "11740687"]}, {"Citation": "Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mole Life Sci. 2021;78(4):1233\u20131261. doi: 10.1007/s00018-020-03656-y.", "ArticleIdList": ["10.1007/s00018-020-03656-y", "PMC7904555", "33057840"]}, {"Citation": "Oh KS, Oh BK, Mun J, Seo HW, Lee BH. Salvianolic acid A suppress lipopolysaccharide-induced NF-\u03baB signaling pathway by targeting IKK\u03b2. Int Immunopharmacol. 2011;11(11):1901\u20131906. doi: 10.1016/j.intimp.2011.07.022.", "ArticleIdList": ["10.1016/j.intimp.2011.07.022", "21839184"]}, {"Citation": "Zeng X, Chen X, Qin H, Han Y, Chen X, Han Z, Zhao W. Preventive effects of a natural anti-inflammatory agent Salvianolic acid A on acute kidney injury in mice. Food Chem Toxicol. 2020;135:110901. doi: 10.1016/j.fct.2019.110901.", "ArticleIdList": ["10.1016/j.fct.2019.110901", "31654708"]}, {"Citation": "Holli Halset J, Hanssen SW, Espinosa A, Klepstad P. Tromboelastography: variability and relation to conventional coagulation test in non-bleeding intensive care unit patients. BMC Anesthesiol. 2015;15:28. doi: 10.1186/s12871-015-0011-2.", "ArticleIdList": ["10.1186/s12871-015-0011-2", "PMC4353683", "25755628"]}, {"Citation": "Madoiwa S. Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC. J Intensive Care. 2015;3:8. doi: 10.1186/s40560-015-0075-6.", "ArticleIdList": ["10.1186/s40560-015-0075-6", "PMC4940964", "27408725"]}, {"Citation": "Plotnikov EY, Brezgunova AA, Pevzner IB, Zorova LD, Manskikh VN, Popkov VA, Silachev DN, Zorov DB. Mechanisms of LPS-induced acute kidney injury in neonatal and adult rats. Antioxidants (Basel) 2018;7(8):105. doi: 10.3390/antiox7080105.", "ArticleIdList": ["10.3390/antiox7080105", "PMC6115895", "30096767"]}, {"Citation": "Wang Z, Bu L, Yang P, Feng S, Xu F. Alleviation of sepsis-induced cardiac dysfunction by overexpression of Sestrin2 is associated with inhibition of p-S6K and activation of the p-AMPK pathway. Mol Med Rep. 2019;20(3):2511\u20132518.", "ArticleIdList": ["PMC6691248", "31524263"]}, {"Citation": "K\u00f6se D, Y\u00fcksel TN, Hal\u0131c\u0131 Z, \u00c7ad\u0131rc\u0131 E, G\u00fcrb\u00fcz MA. The effects of Agomelatine treatment on Lipopolysaccharide-induced septic lung injuries in rats. Eurasian J Med. 2021;53(2):127\u2013131. doi: 10.5152/eurasianjmed.2021.20342.", "ArticleIdList": ["10.5152/eurasianjmed.2021.20342", "PMC8184031", "34177296"]}, {"Citation": "Tong F, Shen W, Song P, Song J, Hu Y, Liu F, Meng Z, Liu J. Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway. Biosci Rep. 2021;41(3):BSR20204279. doi: 10.1042/BSR20204279.", "ArticleIdList": ["10.1042/BSR20204279", "PMC7938455", "33558888"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "27"}, {"Year": "2022", "Month": "9", "Day": "9"}, {"Year": "2022", "Month": "9", "Day": "20", "Hour": "23", "Minute": "39"}, {"Year": "2022", "Month": "9", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["36127691", "PMC9487091", "10.1186/s12906-022-03720-z", "10.1186/s12906-022-03720-z"]}}], "PubmedBookArticle": []}